Hibernating myocardium: Morphological correlates of inotropic stimulation and glucose uptake

Heart

Volumn 83, Issue 4, 2000, Pages 456-461

  Pagano, D ^a   Townend, J N ^a   Parums, D V ^b   Bonser, R S ^a   Camici, P G ^c  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Coronary artery disease; Heart failure; Myocardial blood flow; Myocardial viability; Positron emission tomography

Indexed keywords

CORONARY VASODILATING AGENT; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; GLYCOGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; FEMALE; GLUCOSE TRANSPORT; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN TISSUE; INOTROPISM; MALE; MYOCARDIAL HIBERNATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0034122767     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.4.456     Document Type: Article

References (38)

1. Diamond G, Forrester J, deLuz P, Wyatt H, Swan H. Post-extrasystolic potentiation of ischaemic cardiomyopathy by atrial stimulation. Am Heart J 1978;95:204-9.
2. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary artery bypass surgery for chronic stable angina. Circulation 1985;72(suppl V):V-123-35.
3. Borgers M, Thone F, Wouters L, et al. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol 1993;2:237-45.
4. Flameng W, Wouters L, Sergeant P, et al. Multivariate analysis of angiographic, histologic, electrocardiographic data in patients with coronary artery disease. Circulation 1984;70:7-17.
5. Depré C, Vanoverschelde J, Melin J, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-75.
6. Elsasser AM, Schlepper M, Klovekorn W-P, et al. Hibernating myocardium. An incomplete adaptation to ischemia. Circulation 1997;96:2920-31.
7. Brosius F, Nguyen N, Egert S, et al. Increased sarcolemmal glucose transporter abundance in myocardial ischaemia. Am J Cardiol 1997;80:77-84A.
8. Heusch G, Schulz R. Hibernating myocardium: a review. J Mol Cell Cardiol 1996;28:2359-72.
9. Bonow R. Identification of viable myocardium. Circulation 1996;94:2674-8.
10. Gerber B, Vanovershelde J-L, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9.
11. Camici PG, Wijns W, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997;96:3205-14.
12. McGillem M, DeBoe S, Friedman H, et al. The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairement of reactive hyperemia. Am Heart J 1988;115:970-7.
13. Marzullo P, Parodi O, Sambuceti G, et al. Residual coronary reserve identifies viability in patients with wall motion abnormalities. J Am Coll Cardiol 1995;26:342-50.
14. Picano E, Ostojic M, Varga A, et al. Combined low dose dypiridamole-dobutamine stress echocardiography to identify myocardial viability. Am J Cardiol 1996;27:1422-8.
15. Schulz R, Guth B, Pieper K, et al. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation. Circ Res 1992;70:1282-95.
16. Chen C, Chen L, Prada J, et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995;92:756-66.
17. Zaret BL, Wackers FJ. Nuclear cardiology. N Engl J Med 1993;329:855-63.
18. Pagano D, Bonser R, Townend J, et al. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998;79:281-8.
19. Segar D, Brown S, Sawada S, et al. Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992;19:1197-202.
20. Marinho N, Keogh B, Costa D, et al. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilisation. Circulation 1996;93:737-44.
21. Araujo L, Lammertsma A, Rhodes C, et al. Non-invasive quantification of regional myocardial blood flow in normal volunteers and patients with coronary artery disease using oxygen-15 labelled carbon dioxide inhalation and positron emission tomography. Circulation 1991;83:875-85.
22. Uren N, Melin J, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med 1994;330:1782-8.
23. Ausma J, Cleutjens J, Thone F, et al. Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem 1995; 147:35-42.
24. Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994;90:735-45.
25. Li Q, MacAuley M, Landymore R, et al. Morphometric analysis on myocardial injury related to the use of high volume potassium cardioplegic solution during ischaemic arrest. Pathol Res Pract 1992;188:668-71.
26. Shapiro S, Wilk M. An analysis of variance test for normality. Biometrika 1965;52:591.
27. Fath-Ordoubadi F, Beatt K, Spyrou N, et al. Efficacy of coronary angioplasty for the treatment of hibernating myocardium (in press).
28. Chan R, Lee K, Calafiore P, et al. Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischaemic left ventricular dysfunction. J Am Coll Cardiol 1996;27:1601-7.
29. Perrone-Filardi P, Pace L, Prastraro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201-thallium tomog-raphy versus dobutamine echocardiography. Circulation 1996;94:2712-19.
30. Camici PG, Ferranini E, Opie L. Myocardial metabolism in ischaemic heart disease: basic principles and applications to imaging by positron emission tomography. Progr Cardiovasc Dis 1989;32:217-38.
31. Depré C, Vanovershelde J-L, Taegtmeyer H. Glucose for the heart. Circulation 1999;99:578-88.
32. Ausma J, Furst D, Shivalkar B, et al. Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation. J Mol Cell Cardiol 1995;27:1202-12.
33. Beller A. Comparison of 201-thallium scintigraphy and low-dose dobutamine echocardiography for the non-invasive assessment of myocardial viability. Circulation 1996;94:2681-4.
34. Vanoverschelde J-L, Wijns W, Depré C, et al. Mechanism of chronic regional postischaemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-23.
35. Camici PG, Rimoldi O. Myocardial hibernation vs repetitive stunning in patients. Cardiol Rev 1999;7:39-43.
36. McElroy D, Walker W, Taegtmeyer H. Glycogen loading improves left ventricular function of the rabbit heart after hypothermic ischemic arrest. J Appl Cardiol 1989;4:455-65.
37. Schwarz E, Schoendube F, Kostin S, et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularisation. J Am Coll Cardiol 1998;31:1018-26.
38. Shivalkar B, Maes A, Borgers M, et al. Only hibernating myrocardium invariably shows early recovery after coronary revascularization. Circulation 1996;94:308-15.